Trials / Completed
CompletedNCT02303015
Toxicity Attributed to Genetic Polymorphisms in Testicular Germ Cell Tumor Survivors
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 430 (actual)
- Sponsor
- Rigshospitalet, Denmark · Academic / Other
- Sex
- Male
- Age
- 15 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to identify genetic variations in survivors of testicular cancer and connect these variations to differences in risks of late effects.
Detailed description
Identification of late-effects through questionnaires and linkage to national registries. DNA samples will be gathered through buccal swabs or saliva kits and analysed with whole exome-sequencing.
Conditions
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2023-03-01
- Completion
- 2023-06-01
- First posted
- 2014-11-27
- Last updated
- 2023-11-21
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02303015. Inclusion in this directory is not an endorsement.